Basic Information | Post buying leads | Suppliers |
Name |
Insulin protamine zinc |
EINECS | N/A |
CAS No. | 9004-17-5 | Density | N/A |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | N/A | Boiling Point | N/A |
Molecular Weight | 0 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by subcutaneous and intraperitoneal routes. Experimental teratogenic and reproductive effects. When heated to decomposition it emits toxic fumes of NOx and SOx. A hypoglycemic agent. See also various insulin compounds. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Basal-H-insulin;Depo-insulin; Deposulin; Insulin Retard RI; Insulin zinc protaminate; Insulinzinc protamine; Insulyl-retard; Protamine zinc insulin; Protamine zinc insulininjection; Protamine zinc insulin suspension; Protaphane; Protaphane HM; Zincprotamine insulin; Zinc, with protamine insulin |
Product Name: Insulin protamine zinc
Synonyms of Insulin protamine zinc (CAS NO.9004-17-5) : Depo-insulin;Insulin retard RI ; Inyectable de insulina cinc protamina ; Insulina-zinco protaminato iniettabile ; Inyectable de insulina cinc protamina
CAS NO:9004-17-5
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | subcutaneous | 195iu/kg (195iu/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 153, Pg. 379, 1965. | |
rat | LD50 | intraperitoneal | 830ug/kg (0.83mg/kg) | BEHAVIORAL: ATAXIA ENDOCRINE: HYPOGLYCEMIA | Toxicology and Applied Pharmacology. Vol. 4, Pg. 631, 1962. |
Zinc and its compounds are on the Community Right-To-Know List.
Poison by subcutaneous and intraperitoneal routes. Insulin protamine zinc (CAS NO.9004-17-5) has experimental teratogenic and reproductive effects. When Insulin protamine zinc (CAS NO.9004-17-5) is heated to decomposition ,it emits toxic fumes of NOx and SOx. A hypoglycemic agent. See also various insulin compounds.